The Human Insulin Market was valued at USD 18.1 billion in 2023 and is projected to reach USD 24.6 billion by 2032, expanding at a CAGR of 3.4% during the forecast period of 2024 to 2032. The market growth is driven by the increasing prevalence of diabetes, advancements in insulin delivery systems, and rising awareness about diabetes management globally.Market OverviewHuman insulin is a synthetic form of insulin created using recombinant DNA technology to mimic the insulin n...
more